Andrew S. Ittleman, Esq.

More from Andrew S. Ittleman, Esq.
FDA & Autologous Medicine
FDA & Autologous Medicine
The FDA fires a shot across the bow of the regenerative medicine industry with three new draft guidance documents.
May 4th, 2015